Danilo Menichelli

Pubblicazioni

Titolo Pubblicato in Anno
Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management: a case report EUROPEAN HEART JOURNAL. CASE REPORTS 2023
A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
How to treat patients with splanchnic vein thrombosis: recent advances POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ 2023
Association of proprotein convertase subtilisin/kexin type 9 (PCSK9) levels with abnormally high ankle-brachial index in atrial fibrillation KARDIOLOGIA POLSKA 2023
Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry EUROPEAN JOURNAL OF INTERNAL MEDICINE 2023
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review AUTOIMMUNITY REVIEWS 2023
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2023
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease: A comprehensive systematic-review and meta-analysis THROMBOSIS RESEARCH 2023
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis JOURNAL OF THROMBOSIS AND HAEMOSTASIS 2023
Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium? AMERICAN HEART JOURNAL 2023
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS 2023
Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation. impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients THROMBOSIS AND HAEMOSTASIS 2022
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2022
Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease NUTRIENTS 2022
Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. Insights from the nationwide PLECTRUM registry PLATELETS 2022
Clinical phenotypes of atrial fibrillation and mortality risk-a cluster analysis from the nationwide italian START registry JOURNAL OF PERSONALIZED MEDICINE 2022
Fibrosis-4 (FIB-4) index and mortality in COVID-19 patients admitted to the emergency department INTERNAL AND EMERGENCY MEDICINE 2022
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF). a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study THE LANCET 2022
Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis INTERNAL AND EMERGENCY MEDICINE 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma